市場調查報告書
商品編碼
1577185
到 2030 年先進傷口護理和閉合市場預測:按產品類型、傷口類型、最終用戶和地區進行的全球分析Advanced Wound Care and Closure Market Forecasts to 2030 - Global Analysis By Product Type (Dressings, Negative Pressure Wound Therapy, Skin Substitutes and Other Product Types), Wound Type, End User and By Geography |
根據 Stratistics MRC 的數據,2024 年全球先進傷口護理和閉合市場規模為 222 億美元,預計到 2030 年將達到 332 億美元,預測期內複合年成長率為 6.2%。
傷口護理和閉合是一種專門的醫療干預產品,用於管理和加速複雜傷口的癒合,包括外傷或手術引起的急性傷口,以及糖尿病足潰瘍、壓瘡和靜脈性腿部潰瘍等慢性傷口。所有傷口縫合產品包括先進的敷料、皮膚替代、負壓傷口護理(NPWT)、組織黏合劑、U形釘和縫合線。這些治療旨在改善患者的治療效果、促進癒合並阻止感染。
根據美國政府估計,到2060年,老年人口將超過7,700萬人。據估計,美國約有 2% 的人口患有慢性傷口。
慢性病增加
糖尿病、肥胖症和心血管疾病等慢性疾病的增加是先進傷口護理和閉合市場的主要驅動力。這些疾病通常會導致糖尿病足潰瘍、壓瘡和腿部靜脈潰瘍等慢性傷口,需要先進的創傷護理解決方案。更容易感染這些疾病的人口老化進一步加速了這一趨勢。慢性傷口患者數量的增加增加了對先進創傷護理產品和技術的需求,推動了市場成長。
高級傷口護理產品價格高昂
先進傷口護理產品的高價格是市場成長的主要限制因素。這些產品通常採用先進的技術和材料,導致製造成本更高,最終用戶的價格也更高。對於許多患者來說,這可能是一筆昂貴的費用,特別是在開發中國家和醫療保健覆蓋範圍有限的地區。這些成本因素可能導致某些地區的採用率降低和市場滲透率有限。
再生醫學的進展
再生醫學的進展集中在受損組織和器官的修復、替換和再生,為複雜的創傷治療提供了有前途的解決方案。幹細胞療法、組織工程和生長因子等創新正在為慢性和急性傷口護理開闢新途徑。這些技術有可能加速癒合、減少疤痕並改善患者的治療效果。隨著研究的進展和臨床應用的擴大,再生醫學方法可能會被納入先進的傷口護理方案中。
產品召回與安全問題
產品缺陷、副作用和意外併發症的發生可能導致召回,損害主要企業的聲譽和消費者的信任。此類事件可能會導致製造商受到監管審查、法律責任和經濟損失。隨著醫療保健專業人員變得更加謹慎,安全問題也可能減緩新技術的採用。此外,圍繞這些問題的負面宣傳可能會影響整個行業並減緩市場成長。
COVID-19 大流行最初擾亂了高級創傷護理和傷口縫合市場,導致供應鏈問題和非緊急程序的推遲。然而,它也強調了先進的創傷護理在預防 COVID-19 患者併發症方面的重要性。這次疫情加速了傷口護理管理遠端醫療解決方案的採用,並凸顯了傷口護理方案中感染控制的必要性。這些變化可能會對市場趨勢和產品開拓持久影響。
預計敷料材料產業在預測期內將是最大的產業。
預計敷料材料領域將在預測期內佔據市場佔有率。這項優點是由於可用的敷料種類繁多,包括泡棉敷料、親水膠體敷料、藻酸鹽敷料和抗菌敷料,每種敷料都針對特定的傷口類型和癒合階段量身定做。先進敷料適用於從慢性潰瘍到手術傷口等各種傷口狀況的多功能性和有效性,有助於其廣泛使用。此外,敷料材料和設計的不斷創新,例如帶有傷口監測感測器的智慧敷料,進一步支持了該領域的成長。
傷口護理(NPWT)領域預計在預測期內複合年成長率最高
在預測期內,負壓傷口護理(NPWT)領域預計將以最高複合年成長率成長。這種快速成長是由於人們越來越認知到 NPWT 可有效治療複雜且難以癒合的傷口。 NPWT 系統透過創建受控的負壓環境來去除多餘的液體、減少水腫並刺激肉芽組織的形成,從而促進更快的癒合。它在治療各種傷口類型方面的多功能性,包括外科性創傷、壓瘡和糖尿病足潰瘍,有助於該技術的廣泛採用。
預計北美地區在預測期內將佔據最大的市場佔有率。這項優勢可歸因於多種因素,包括該地區完善的醫療基礎設施、高昂的醫療成本以及較早採用先進醫療技術。糖尿病和肥胖症等慢性疾病的盛行率在北美也較高,這些疾病往往會導致複雜的傷口。該地區擁有強大的主要市場參與者,促進創新和產品供應。此外,先進傷口護理產品的優惠報銷政策和人口老化的加劇也有助於擴大市場規模。
預計亞太地區在預測期內將實現最高的複合年成長率。這種快速成長背後有幾個因素,包括該地區人口的成長、醫療保健支出的增加以及醫療保健基礎設施的改善。慢性病盛行率的上升以及對先進傷口護理技術認知的提高正在推動市場擴張。中國和印度等政府正大力投資醫療保健現代化,為引進先進傷口護理創造機會。該地區醫療旅遊業的擴張也促進了市場的擴張。
According to Stratistics MRC, the Global Advanced Wound Care and Closure Market is accounted for $22.2 billion in 2024 and is expected to reach $33.2 billion by 2030, growing at a CAGR of 6.2% during the forecast period. Advanced wound care and closure are specialized medical interventions and products used to manage and speed up the healing of complex wounds, such as acute wounds from trauma or surgery, as well as chronic wounds like diabetic foot ulcers, pressure ulcers, and venous leg ulcers. Advanced dressings, skin substitutes, negative pressure wound therapy (NPWT), and closure products such as tissue adhesives, staples, and sutures are all included. These remedies seek to improve patient outcomes, promote healing, and stop infection.
According to the U.S. government estimates, by the year 2060, the elderly population will be over 77 million. Overall, in the United States approximately 2% of the total population are estimated to be affected by chronic wounds.
Rising prevalence of chronic diseases
The increasing prevalence of chronic diseases, such as diabetes, obesity, and cardiovascular disorders, is a significant driver for the advanced wound care and closure market. These conditions often lead to chronic wounds, including diabetic foot ulcers, pressure ulcers, and venous leg ulcers, which require advanced wound care solutions. The growing aging population, which is more susceptible to these diseases, further amplifies this trend. As the number of patients with chronic wounds rises, the demand for advanced wound care products and technologies increases, driving market growth.
High cost of advanced wound care products
The high cost of advanced wound care products poses a significant restraint to market growth. These products often incorporate sophisticated technologies and materials, resulting in higher production costs and, consequently, higher prices for end-users. The expense can be prohibitive for many patients, especially in developing countries or areas with limited healthcare coverage. The cost factor can lead to slower adoption rates and limited market penetration in certain regions.
Advancements in regenerative medicine
Advancements in regenerative medicine focus on repairing, replacing, or regenerating damaged tissues and organs, offering promising solutions for complex wound healing. Innovations in stem cell therapy, tissue engineering, and growth factors are opening new avenues for treating chronic and acute wounds. These technologies have the potential to accelerate healing, reduce scarring, and improve overall patient outcomes. As research progresses and clinical applications expand, regenerative medicine approaches are likely to become more integrated into advanced wound care protocols.
Product recalls and safety concerns
Incidents of product defects, adverse reactions, or unforeseen complications can lead to recalls, damaging both company reputations and consumer trust. Such events may result in regulatory scrutiny, legal liabilities, and financial losses for manufacturers. Safety concerns can also slow down the adoption of new technologies as healthcare providers become more cautious. Additionally, negative publicity surrounding these issues can impact the entire industry, potentially slowing market growth.
The COVID-19 pandemic initially disrupted the advanced wound care and closure market, causing supply chain issues and postponement of non-emergency procedures. However, it also highlighted the importance of advanced wound care in preventing complications in COVID-19 patients. The pandemic accelerated the adoption of telehealth solutions for wound care management and emphasized the need for infection control measures in wound treatment protocols. These changes are likely to have lasting effects on market trends and product development.
The dressings segment is expected to be the largest during the forecast period
Over the forecasted timeframe, the dressings segment is anticipated to dominate the market share. This dominance can be attributed to the wide range of dressing types available, including foam dressings, hydrocolloid dressings, alginate dressings, and antimicrobial dressings, each catering to specific wound types and healing stages. The versatility and effectiveness of advanced dressings in managing various wound conditions, from chronic ulcers to surgical wounds, contribute to their widespread use. Additionally, ongoing innovations in dressing materials and designs, such as smart dressings with sensors for wound monitoring, are further driving the segment's growth.
The negative pressure wound therapy (NPWT) segment is expected to have the highest CAGR during the forecast period
During the projection period, the negative pressure wound therapy (NPWT) segment is expected to grow at the highest CAGR. This rapid growth can be attributed to the increasing recognition of NPWT's effectiveness in managing complex and hard-to-heal wounds. NPWT systems promote faster healing by creating a controlled negative pressure environment that removes excess fluid, reduces edema, and stimulates granulation tissue formation. The technology's versatility in treating various wound types, including surgical wounds, pressure ulcers, and diabetic foot ulcers, contributes to its growing adoption.
During the estimation period, the North America region is expected to capture the largest market share. This dominance can be attributed to several factors, including the region's well-established healthcare infrastructure, high healthcare expenditure, and early adoption of advanced medical technologies. The prevalence of chronic diseases such as diabetes and obesity, which often lead to complex wounds, is also higher in North America. The region benefits from a strong presence of key market players, driving innovation and product availability. Additionally, favorable reimbursement policies for advanced wound care products and a growing aging population contribute to the market's size.
The Asia Pacific region is projected to achieve the highest CAGR during the forecast period. This rapid growth can be attributed to several factors, including the region's large and growing population, increasing healthcare expenditure, and improving healthcare infrastructure. The rising prevalence of chronic diseases, coupled with a growing awareness of advanced wound care techniques, is driving market expansion. Governments in countries like China and India are investing heavily in healthcare modernization, creating opportunities for advanced wound care adoption. The region's expanding medical tourism industry also contributes to market growth.
Key players in the market
Some of the key players in Advanced Wound Care and Closure Market include 3M Company, Smith & Nephew plc, ConvaTec Group plc, Coloplast A/S, Molnlycke Health Care AB, B. Braun Melsungen AG, Johnson & Johnson, Medtronic plc, Cardinal Health, Inc., Paul Hartmann AG, Integra LifeSciences Holdings Corporation, Baxter International Inc., Essity AB, Acelity L.P. Inc., Organogenesis Holdings Inc., Hollister Incorporated, MiMedx Group, Inc., and Ethicon, Inc.
In October 2024, Molnlycke Health Care AB acquired P.G.F. Industry Solutions GmbH, the manufacturer of Granudacyn wound cleansing and moisturizing solutions, to expand its wound care portfolio.
In April 2024, Smith+Nephew, the global medical technology company, is pleased to announce the launch of its RENASYS EDGE Negative Pressure Wound Therapy (NPWT) System in the US as a patient-centric option for treating chronic wounds. The system is lightweight and compact, allowing it to be easily carried or worn. It features a discreet canister and operates quietly so as not to draw attention or disturb the patients' daily activities.
In January 2024, 3M Company received a $34.2 million award from the U.S. Army Medical Research Acquisition Activity to develop new solutions for infection prevention, wound management, and wound healing, focusing on treatment strategies for emergency settings and mass casualty situations.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.